Pages that link to "Q37309900"

The following pages link to Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia. (Q37309900):

Displaying 29 items.

• α:Non-α and Gγ:Aγ globin chain ratios in thalassemia intermedia patients treated with hydroxyurea. (Q33628874) (← links)
• Fetal globin induction in beta-thalassemia (Q34087414) (← links)
• Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation (Q34248320) (← links)
• The in vitro antisickling and antioxidant effects of aqueous extracts Zanthoxyllum heitzii on sickle cell disorder. (Q34800338) (← links)
• Screening Antitumor Compounds Psoralen and Isopsoralen from Psoralea corylifolia L. Seeds (Q35102416) (← links)
• Dissection of the radical reactions linked to fetal hemoglobin reveals enhanced pseudoperoxidase activity (Q35104057) (← links)
• The Ethanol Extract of Fructus trichosanthis Promotes Fetal Hemoglobin Production via p38 MAPK Activation and ERK Inactivation in K562 Cells. (Q35184626) (← links)
• Role of XmnIgG Polymorphism in Hydroxyurea Treatment and Fetal Hemoglobin Level at Isfahanian Intermediate β-Thalassemia Patients (Q36062896) (← links)
• Production of beta-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta(0)39 thalassemia patients (Q36611332) (← links)
• Comparison of in-vitro and in-vivo response to fetal hemoglobin production and γ-mRNA expression by hydroxyurea in Hemoglobinopathies (Q37136101) (← links)
• Alternative options for DNA-based experimental therapy of β-thalassemia. (Q37993118) (← links)
• Recent trends for novel options in experimental biological therapy of β-thalassemia (Q38220695) (← links)
• Recent trends in the gene therapy of β-thalassemia (Q38367473) (← links)
• Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation. (Q38879274) (← links)
• Radix Astragali Stimulates p38 MARK Phosphorylation in Pediatric Patients with β-Thalassemia (Q39157431) (← links)
• Piceatannol: a potential futuristic natural stilbene as fetal haemoglobin inducer (Q39248188) (← links)
• Phytochemical and pharmacological properties of essential oils from Cedrus species (Q39410705) (← links)
• C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells. (Q39465808) (← links)
• Erythroid induction of chronic myelogenous leukemia K562 cells following treatment with a photoproduct derived from the UV-A irradiation of 5-methoxypsoralen. (Q39678044) (← links)
• Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs (Q39795854) (← links)
• The management of sickle cell disease in a primary care setting (Q41875605) (← links)
• Predictive analyses of biological effects of natural products: from plant extracts to biomolecular laboratory and computer modeling (Q42121661) (← links)
• Cucurbitacin D induces fetal hemoglobin synthesis in K562 cells and human hematopoietic progenitors through activation of p38 pathway and stabilization of the γ-globin mRNA (Q42868264) (← links)
• Foetal haemoglobin inducers and thalassaemia: novel achievements (Q42933281) (← links)
• A reduced curcuminoid analog as a novel inducer of fetal hemoglobin. (Q44238537) (← links)
• Pharmacological and molecular approaches for the treatment of β-hemoglobin disorders. (Q45874809) (← links)
• Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia (Q45888439) (← links)
• Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study. (Q47555336) (← links)
• Consensus Predictive Model for Human K562 Cell Growth Inhibition through Enalos Cloud Platform (Q47806909) (← links)